Candriam SCA’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $41.3M | Buy |
106,132
+15,869
| +18% | +$6.71M | 0.19% | 114 |
|
|
2026
Q1 | $42.7M | Sell |
90,263
-10,738
| -11% | -$5.41M | 0.22% | 102 |
|
|
2025
Q4 | $47.2M | Buy |
101,001
+1,899
| +2% | +$882K | 0.24% | 96 |
|
|
2025
Q3 | $42.2M | Sell |
99,102
-62,538
| -39% | -$24.2M | 0.22% | 101 |
|
|
2025
Q2 | $61.9M | Buy |
161,640
+5,069
| +3% | +$1.83M | 0.36% | 71 |
|
|
2025
Q1 | $54.1M | Sell |
156,571
-8,034
| -5% | -$2.58M | 0.34% | 74 |
|
|
2024
Q4 | $49.4M | Buy |
164,605
+55,117
| +50% | +$19.3M | 0.28% | 80 |
|
|
2024
Q3 | $44.5M | Buy |
109,488
+18,845
| +21% | +$6.9M | 0.26% | 83 |
|
|
2024
Q2 | $29.1M | Sell |
90,643
-8,190
| -8% | -$2.66M | 0.18% | 123 |
|
|
2024
Q1 | $33M | Buy |
98,833
+233
| +0.2% | +$71.2K | 0.21% | 114 |
|
|
2023
Q4 | $26.7M | Buy |
98,600
+17,429
| +21% | +$4.31M | 0.18% | 121 |
|
|
2023
Q3 | $20M | Buy |
81,171
+29,709
| +58% | +$8.13M | 0.14% | 143 |
|
|
2023
Q2 | $15.6M | Sell |
51,462
-44,614
| -46% | -$12.4M | 0.11% | 189 |
|
|
2023
Q1 | $23.3M | Buy |
96,076
+11,961
| +14% | +$3.04M | 0.16% | 147 |
|
|
2022
Q4 | $20.2M | Sell |
84,115
-34,829
| -29% | -$7.8M | 0.14% | 166 |
|
|
2022
Q3 | $21.9M | Sell |
118,944
-29,618
| -20% | -$5.9M | 0.15% | 149 |
|
|
2022
Q2 | $25M | Buy |
148,562
+37,923
| +34% | +$8.15M | 0.21% | 116 |
|
|
2022
Q1 | $27.7M | Sell |
110,639
-11,071
| -9% | -$2.78M | 0.19% | 124 |
|
|
2021
Q4 | $31.3M | Buy |
121,710
+96,759
| +388% | +$23.7M | 0.2% | 128 |
|
|
2021
Q3 | $6.06M | Sell |
24,951
-6,207
| -20% | -$1.52M | 0.04% | 362 |
|
|
2021
Q2 | $6.44M | Sell |
31,158
-33,597
| -52% | -$6.85M | 0.04% | 359 |
|
|
2021
Q1 | $10.2M | Hold |
64,755
| – | – | 0.09% | 247 |
|
|
2020
Q4 | $10.7M | Buy |
64,755
+13,100
| +25% | +$1.92M | 0.08% | 251 |
|
|
2020
Q3 | $6.44M | Sell |
51,655
-81,539
| -61% | -$10.1M | 0.06% | 314 |
|
|
2020
Q2 | $12.9M | Buy |
133,194
+23,185
| +21% | +$2.41M | 0.14% | 174 |
|
|
2020
Q1 | $15.9M | Hold |
110,009
| – | – | 0.18% | 133 |
|
|
2019
Q4 | $16.3M | Buy |
110,009
+10,700
| +11% | +$1.44M | 0.17% | 133 |
|
|
2019
Q3 | $12M | Sell |
99,309
-660
| -0.7% | -$85.3K | 0.16% | 152 |
|
|
2019
Q2 | $13.5M | Buy |
99,969
+12,036
| +14% | +$1.52M | 0.17% | 140 |
|
|
2019
Q1 | $11.5M | Sell |
87,933
-85,013
| -49% | -$11.4M | 0.15% | 162 |
|
|
2018
Q4 | $21.5M | Buy |
172,946
+27,451
| +19% | +$3.68M | 0.33% | 58 |
|
|
2018
Q3 | $20.2M | Buy |
145,495
+23,899
| +20% | +$2.98M | 0.27% | 83 |
|
|
2018
Q2 | $12.5M | Sell |
121,596
-39,284
| -24% | -$3.97M | 0.2% | 133 |
|
|
2018
Q1 | $15.6M | Sell |
160,880
-69,564
| -30% | -$6.75M | 0.27% | 99 |
|
|
2017
Q4 | $20.2M | Sell |
230,444
-169,340
| -42% | -$13.6M | 0.35% | 73 |
|
|
2017
Q3 | $31.8M | Buy |
399,784
+15,576
| +4% | +$1.25M | 0.56% | 35 |
|
|
2017
Q2 | $33.5M | Buy |
384,208
+23,658
| +7% | +$2M | 0.63% | 27 |
|
|
2017
Q1 | $32.1M | Buy |
360,550
+155,639
| +76% | +$13M | 0.62% | 25 |
|
|
2016
Q4 | $15.2M | Buy |
204,911
+65,651
| +47% | +$4.92M | 0.35% | 72 |
|
|
2016
Q3 | $10.5M | Sell |
139,260
-17,434
| -11% | -$1.33M | 0.25% | 100 |
|
|
2016
Q2 | $12.1M | Sell |
156,694
-19,689
| -11% | -$1.55M | 0.31% | 83 |
|
|
2016
Q1 | $13.7M | Sell |
176,383
-29,592
| -14% | -$2.07M | 0.34% | 76 |
|
|
2015
Q4 | $13.9M | Buy |
205,975
+25,251
| +14% | +$1.76M | 0.37% | 68 |
|
|
2015
Q3 | $14M | Buy |
180,724
+42,473
| +31% | +$3.76M | 0.34% | 82 |
|
|
2015
Q2 | $12.5M | Sell |
138,251
-4,216
| -3% | -$338K | 0.26% | 105 |
|
|
2015
Q1 | $10.7M | Buy |
142,467
+108,643
| +321% | +$7.8M | 0.22% | 137 |
|
|
2014
Q4 | $2.48M | Buy |
+33,824
| New | +$2.38M | 0.05% | 331 |
|
Other funds holding HCA
Candriam SCA's HCA Position: Q2 2026 in Review
Candriam SCA increased its HCA Healthcare (HCA) stake by 18% in Q2 2026, buying an estimated $6.71M and bringing the position to 106,132 shares worth $41.3M. The position accounts for 0.19% of the portfolio, ranked #114.
Candriam SCA first reported a position in HCA in Q4 2014 and has held it in 47 quarters since. The position peaked at $61.9M in Q2 2025. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- Candriam SCA held 106,132 shares of HCA Healthcare worth $41.3M as of Q2 2026.
- Candriam SCA bought 15,869 HCA Healthcare shares in Q2 2026, an estimated $6.71M.
- HCA Healthcare made up 0.19% of Candriam SCA's portfolio in Q2 2026, its #114 holding.
- Candriam SCA first reported a position in HCA Healthcare in Q4 2014 and has held it in 47 quarters since.
- Candriam SCA's HCA Healthcare position peaked at $61.9M in Q2 2025.
- 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.